Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
医学
内科学
系统性红斑狼疮
狼疮性肾炎
免疫学
红斑狼疮
抗体
疾病
作者
David Jayne,Brad H. Rovin,Eduardo Mysler,Richard Furie,Frédéric Houssiau,Teodora Trasieva,J. Knagenhjelm,Erik Schwetje,Yen Lin Chia,Raj Tummala,Catharina Lindholm
To assess the efficacy and safety of the type I interferon receptor antibody, anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis.
PDF的下载单位、IP信息已删除
(2025-6-4)
Riverchase
GingerF
盘菜
乐空思
F二次方
xzy998
Criminology34
干净的琦
无极微光
昏睡的蟠桃
Semy
识字岭的岭
Singularity
eric888
殷勤的紫槐
缓慢怜菡
海蓝云天
徐华
xiaofei
猪猪hero
皖公网安备34019202002308
